T1	missed_chemical 54 57	PLP
T2	missed_chemical 62 65	DOX
T3	disease_or_phenotypic_feature 69 77	melanoma
T4	disease_or_phenotypic_feature 151 156	tumor
T5	chemical 173 182	oxidative
T6	disease_or_phenotypic_feature 323 326	RAd
T7	disease_or_phenotypic_feature 335 348	cerviX cancer
T8	chemical 433 440	radical
T9	disease_or_phenotypic_feature 701 704	CSP
T10	chemical 758 764	sodium
T11	chemical 776 822	tetrakis[3,5-bis(trifluoromethyl)phenyl]borate
T12	chemical 776 828	tetrakis[3,5-bis(trifluoromethyl)phenyl]borate salts
T13	chemical 893 911	[hexane-2-propanol
T14	chemical 943 951	Paraquat
T15	disease_or_phenotypic_feature 956 975	Parkinson's disease
T16	chemical 1104 1114	inhibitors
T17	chemical 1176 1190	drug-resistant
T18	disease_or_phenotypic_feature 1191 1202	influenza A
T19	disease_or_phenotypic_feature 1223 1232	influenza
T20	disease_or_phenotypic_feature 1261 1279	influenza-infected
T21	chemical 1303 1312	Chalcones
T22	chemical 1343 1347	drug
T23	disease_or_phenotypic_feature 1388 1395	malaria
T24	chemical 1458 1468	biomarkers
T25	disease_or_phenotypic_feature 1537 1551	Chagas disease
T26	chemical 1619 1623	mRNA
T27	chemical 1628 1635	protein
T28	disease_or_phenotypic_feature 1733 1739	injury
T29	chemical 1847 1857	eplerenone
T31	disease_or_phenotypic_feature 1883 1915	central serous chorioretinopathy
T32	chemical 1982 1986	CGRP
T33	disease_or_phenotypic_feature 2019 2027	Migraine
T34	chemical 2169 2179	biomarkers
T35	disease_or_phenotypic_feature 2223 2236	breast cancer
T36	chemical 2363 2369	oxygen
T37	disease_or_phenotypic_feature 2400 2423	obstructive sleep apnea
T38	chemical 2472 2475	NPC
T39	disease_or_phenotypic_feature 2472 2475	NPC
T40	chemical 2600 2603	RNA
T41	disease_or_phenotypic_feature 2662 2673	sensitivity
T42	chemical 2764 2772	Nanorods
T43	chemical 2794 2803	Porphyrin
T44	disease_or_phenotypic_feature 2868 2878	Anti-tumor
T45	chemical 2971 2987	dabrafenib-based
T46	disease_or_phenotypic_feature 3005 3013	melanoma
T47	chemical 3066 3073	retinal
T48	chemical 3074 3084	biomarkers
T49	chemical 3118 3127	retinitis
T50	disease_or_phenotypic_feature 3118 3138	retinitis pigmentosa
T51	disease_or_phenotypic_feature 3316 3321	tumor
T52	disease_or_phenotypic_feature 3360 3365	tumor
T53	chemical 3392 3408	immunomodulation
T54	chemical 3413 3417	drug
T56	disease_or_phenotypic_feature 3573 3595	acute myeloid leukemia
T57	disease_or_phenotypic_feature 3597 3601	AML)
T58	corrected_chemical 3666 3689	Topical Corticosteroids
T59	chemical 3674 3689	Corticosteroids
T61	disease_or_phenotypic_feature 3728 3745	Atopic Dermatitis
R1	treats Arg1:T1 Arg2:T4
R2	treats Arg1:T1 Arg2:T3
R3	treats Arg1:T2 Arg2:T3
R4	treats Arg1:T2 Arg2:T4
R5	treats Arg1:T36 Arg2:T37
R6	treats Arg1:T22 Arg2:T23
R7	treats Arg1:T21 Arg2:T23
R8	treats Arg1:T58 Arg2:T61
R10	treats Arg1:T54 Arg2:T51
T62	corrected_chemical 1090 1114	neuraminidase inhibitors
T63	corrected_chemical 1176 1180	drug
T64	corrected_disease_or_phenotypic_feature 1223 1234	influenza B
T65	corrected_disease_or_phenotypic_feature 1261 1270	influenza
T66	missed_chemical 1126 1135	compounds
R11	treats Arg1:T62 Arg2:T18	
R13	treats Arg1:T66 Arg2:T18	
R14	treats Arg1:T66 Arg2:T64	
T68	corrected_chemical 2971 2981	dabrafenib
R16	treats Arg1:T68 Arg2:T46	
T69	corrected_chemical 3516 3539	antibody-drug conjugate
T70	missed_chemical 3447 3468	Gemtuzumab ozogamicin
R19	treats Arg1:T69 Arg2:T56	
T72	corrected_disease_or_phenotypic_feature 3597 3600	AML
R20	treats Arg1:T69 Arg2:T72	
R21	treats Arg1:T70 Arg2:T56	
R22	treats Arg1:T70 Arg2:T72	
R23	causes_or_contributes_to Arg1:T14 Arg2:T15	
R24	treats Arg1:T63 Arg2:T18	
R12	treats Arg1:T66 Arg2:T65	
R15	treats Arg1:T62 Arg2:T65	
R25	treats Arg1:T62 Arg2:T64	
T30	missed_chemical 3695 3714	Vehicle/Moisturizer
R17	treats Arg1:T30 Arg2:T61	
T55	missed_disease_or_phenotypic_feature 1240 1257	improved survival
R18	causes_or_contributes_to Arg1:T66 Arg2:T55	
T60	missed_chemical 1797 1807	etanercept
T67	corrected_disease_or_phenotypic_feature 1714 1739	penetrating ocular injury
R26	treats Arg1:T60 Arg2:T67	
T71	corrected_chemical 2749 2817	Supramolecular Nanorods of (N-Methylpyridyl) Porphyrin With Captisol
T73	missed_disease_or_phenotypic_feature 2849 2863	Anti-bacterial
R27	causes_or_contributes_to Arg1:T71 Arg2:T73	
R28	causes_or_contributes_to Arg1:T71 Arg2:T44	
T74	chemical 3516 3529	antibody-drug
